Richard E. Uihlein - 17 Sep 2021 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Reporting relationship
Director, 10%+ Owner
Issuer ticker
GALT
Reported as of
17 Sep 2021
Net transaction value
+$11,574,070,000,000
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Sep 2021, 16:30:15 UTC
Next SEC filing
25 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jack W. Callicutt, by power of attorney

Key filing fact

Richard E. Uihlein filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 21 Sep 2021.

Key facts

  • This page summarizes Richard E. Uihlein's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 21 Sep 2021, 16:30.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$11,574,070,000,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GALT transaction Derivative

Convertible Note

Award

Transaction value
$11,574,070,000,000
Shares
+1,157,407
Change %
+13%
Price
$10000000.00*
Shares after
10,000,000
Date
17 Sep 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,157,407
Exercise price
$8.64
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Excludes interest that may accrue following issuance of the Note.

Footnote F2

The Note is convertible upon 60 days prior written notice by the noteholder.

Footnote F3

In consideration for the Convertible Note, the Reporting Person loaned ten million dollars to the Company.

Footnote F4

Represents the principal amount of the note payable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .